Proceedings (Baylor University. Medical Center) · 2026
The urological burden of lichen sclerosis: implications for multidisciplinary surveillance and management.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lakkuru Rudhasri, Farah Gabriana M, Kapur Sahil, Burkhart Craig G
Аннотация
BACKGROUND: Lichen sclerosis (LS) is a chronic inflammatory condition predominantly affecting the anogenital skin, with genitourinary involvement leading to scarring, phimosis, and voiding dysfunction. The long-term urological sequelae, including urological interventions, remain unexplored in large cohorts.
METHODS: Using the TriNetX database, a retrospective propensity score-matched cohort analysis was conducted, comparing 36,974 patients with LS to 36,974 controls matched by demographics, diabetes mellitus, tobacco use, recurrent urinary tract infections, immunosuppressant use, and prior cystourethroscopy and/or temporary indwelling bladder catheter. Outcomes involved patients with >12 months follow-up with urological complications or urological interventions, identified through ICD-10 codes.
RESULTS: Overall, urethral strictures (relative risk [RR]: 2.256; 95% confidence interval [CI]: 1.753-2.905; P < 0.0001) and urethroplasty (P < 0.0001) rates were significantly elevated in the LS cohort group.
CONCLUSIONS: These findings highlight the multisystematic involvement of LS and emphasize the importance for comprehensive dermatologic and urologic follow-up.
METHODS: Using the TriNetX database, a retrospective propensity score-matched cohort analysis was conducted, comparing 36,974 patients with LS to 36,974 controls matched by demographics, diabetes mellitus, tobacco use, recurrent urinary tract infections, immunosuppressant use, and prior cystourethroscopy and/or temporary indwelling bladder catheter. Outcomes involved patients with >12 months follow-up with urological complications or urological interventions, identified through ICD-10 codes.
RESULTS: Overall, urethral strictures (relative risk [RR]: 2.256; 95% confidence interval [CI]: 1.753-2.905; P < 0.0001) and urethroplasty (P < 0.0001) rates were significantly elevated in the LS cohort group.
CONCLUSIONS: These findings highlight the multisystematic involvement of LS and emphasize the importance for comprehensive dermatologic and urologic follow-up.